Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05288179 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 24, 2025 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Sep 30, 2024 to Sep 30, 2026
    • Study sites: 0 to 1
    • Study completion date: Sep 30, 2025 to Sep 30, 2026
    • Start date changed from estimate of Apr 15, 2022 to Jun 7, 2022
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a randomized, double-blind, placebo-controlled, multicenter clinical study. The main purpose of this study was to confirm the efficacy and safety of pirfenidone capsules in the treatment of pneumoconiosis.
Trial Details
NCT Number NCT05288179
Lead Sponsor Beijing Continent Pharmaceutical Co, Ltd.
Conditions
(from sponsor)		 Pneumoconiosis
Related terms Pneumoconiosis
Enrollment 272 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov